APO Research
Talk to an analyst

APO RESEARCH · REPORT

Single Cell Genomics and Proteomics

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Single Cell Genomics and Proteomics Market Analysis and Forecast 2026-2032

11 April 2026258 pages

Choose your research edition.

Industry ResearchSingle Cell Genomics and Proteomics Industry Research Report 2026119 pages · $2,950 USDIndustry Growth & TrendsGlobal Single Cell Genomics and Proteomics Industry Growth and Trends Forecast to 2032100 pages · $3,450 USDMarket StructureGlobal Single Cell Genomics and Proteomics Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Single Cell Genomics and Proteomics Market Outlook and Growth Opportunities 2026$4,250 USDMarket Analysis & ForecastGlobal Single Cell Genomics and Proteomics Market Analysis and Forecast 2026-2032258 pages · $4,950 USD

Market perspective

The global Single Cell Genomics and Proteomics market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Single Cell Genomics and Proteomics is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Single Cell Genomics and Proteomics is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Single Cell Genomics and Proteomics is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Single Cell Genomics and Proteomics is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Single Cell Genomics and Proteomics include 10x Genomics, Inc., Standard BioTools Inc, QIAGEN GmbH, Thermo Fisher Scientific Inc., Agilent Technologies, Inc., Exact Sciences Corporation, Accelerate Diagnostics, Inc., Bio-Rad Laboratories, Inc. and Epic Sciences, Inc., etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Single Cell Genomics and Proteomics, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Single Cell Genomics and Proteomics, also provides the revenue of main regions and countries. Of the upcoming market potential for Single Cell Genomics and Proteomics, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Single Cell Genomics and Proteomics revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Single Cell Genomics and Proteomics market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Single Cell Genomics and Proteomics revenue, projected growth trends, production technology, application and end-user industry.

Single Cell Genomics and Proteomics Segment by Company

10x Genomics, Inc.

Standard BioTools Inc

QIAGEN GmbH

Thermo Fisher Scientific Inc.

Agilent Technologies, Inc.

Exact Sciences Corporation

Accelerate Diagnostics, Inc.

Bio-Rad Laboratories, Inc.

Epic Sciences, Inc.

Yikon Genomics Co., Ltd.

Takara Bio Inc.

1CellBio, Inc.

Bio-Techne Corporation

Single Cell Genomics and Proteomics Segment by Type

Cell Isolation

Sample Preparation

Genomic Analysis

Single Cell Genomics and Proteomics Segment by Application

Genomic Variation

Subpopulation Characterization

Circulating Tumor Cells

Cell Differentiation

Others

Single Cell Genomics and Proteomics Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Single Cell Genomics and Proteomics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Single Cell Genomics and Proteomics and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Single Cell Genomics and Proteomics.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Single Cell Genomics and Proteomics in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Single Cell Genomics and Proteomics company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Single Cell Genomics and Proteomics revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Single Cell Genomics and Proteomics Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Cell Isolation Major Player Table 3. Sample Preparation Major Player Table 4. Genomic Analysis Major Player Table 5. Global Single Cell Genomics and Proteomics Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Genomic Variation Major Player Table 7. Subpopulation Characterization Major Player Table 8. Circulating Tumor Cells Major Player Table 9. Cell Differentiation Major Player Table 10. Others Major Player Table 11. Single Cell Genomics and Proteomics Industry Trends Table 12. Single Cell Genomics and Proteomics Industry Drivers Table 13. Single Cell Genomics and Proteomics Industry Opportunities and Challenges Table 14. Single Cell Genomics and Proteomics Industry Restraints Table 15. Global Single Cell Genomics and Proteomics Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 16. Global Single Cell Genomics and Proteomics Market Size by Region (2021-2026) & (US$ Million) Table 17. Global Single Cell Genomics and Proteomics Market Share by Region (2021-2026) Table 18. Global Single Cell Genomics and Proteomics Market Size by Region (2027-2032) & (US$ Million) Table 19. Global Single Cell Genomics and Proteomics Market Share by Region (2027-2032) Table 20. Global Single Cell Genomics and Proteomics Revenue by Players (US$ Million) & (2021-2026) Table 21. Global Single Cell Genomics and Proteomics Revenue Market Share by Players (2021-2026) Table 22. Global Single Cell Genomics and Proteomics Key Players Ranking, 2024 VS 2025 VS 2026 Table 23. Global Single Cell Genomics and Proteomics Key Players Headquarters & Area Served Table 24. Global Single Cell Genomics and Proteomics Players, Product Type & Application Table 25. Global Single Cell Genomics and Proteomics Players Establishment Date Table 26. Global Players Market Concentration Ratio (CR5 and HHI) Table 27. Global Single Cell Genomics and Proteomics by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 28. Global Single Cell Genomics and Proteomics Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global Single Cell Genomics and Proteomics Revenue by Type (2021-2026) & (US$ Million) Table 30. Global Single Cell Genomics and Proteomics Revenue by Type (2027-2032) & (US$ Million) Table 31. Global Single Cell Genomics and Proteomics Revenue Market Share by Type (2021-2026) Table 32. Global Single Cell Genomics and Proteomics Revenue Market Share by Type (2027-2032) Table 33. Global Single Cell Genomics and Proteomics Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Single Cell Genomics and Proteomics Revenue by Application (2021-2026) & (US$ Million) Table 35. Global Single Cell Genomics and Proteomics Revenue by Application (2027-2032) & (US$ Million) Table 36. Global Single Cell Genomics and Proteomics Revenue Market Share by Application (2021-2026) Table 37. Global Single Cell Genomics and Proteomics Revenue Market Share by Application (2027-2032) Table 38. 10x Genomics, Inc. Company Information Table 39. 10x Genomics, Inc. Business Overview Table 40. 10x Genomics, Inc. Single Cell Genomics and Proteomics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 41. 10x Genomics, Inc. Single Cell Genomics and Proteomics Product Portfolio Table 42. 10x Genomics, Inc. Recent Development Table 43. Standard BioTools Inc Company Information Table 44. Standard BioTools Inc Business Overview Table 45. Standard BioTools Inc Single Cell Genomics and Proteomics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 46. Standard BioTools Inc Single Cell Genomics and Proteomics Product Portfolio Table 47. Standard BioTools Inc Recent Development Table 48. QIAGEN GmbH Company Information Table 49. QIAGEN GmbH Business Overview Table 50. QIAGEN GmbH Single Cell Genomics and Proteomics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 51. QIAGEN GmbH Single Cell Genomics and Proteomics Product Portfolio Table 52. QIAGEN GmbH Recent Development Table 53. Thermo Fisher Scientific Inc. Company Information Table 54. Thermo Fisher Scientific Inc. Business Overview Table 55. Thermo Fisher Scientific Inc. Single Cell Genomics and Proteomics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 56. Thermo Fisher Scientific Inc. Single Cell Genomics and Proteomics Product Portfolio Table 57. Thermo Fisher Scientific Inc. Recent Development Table 58. Agilent Technologies, Inc. Company Information Table 59. Agilent Technologies, Inc. Business Overview Table 60. Agilent Technologies, Inc. Single Cell Genomics and Proteomics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 61. Agilent Technologies, Inc. Single Cell Genomics and Proteomics Product Portfolio Table 62. Agilent Technologies, Inc. Recent Development Table 63. Exact Sciences Corporation Company Information Table 64. Exact Sciences Corporation Business Overview Table 65. Exact Sciences Corporation Single Cell Genomics and Proteomics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 66. Exact Sciences Corporation Single Cell Genomics and Proteomics Product Portfolio Table 67. Exact Sciences Corporation Recent Development Table 68. Accelerate Diagnostics, Inc. Company Information Table 69. Accelerate Diagnostics, Inc. Business Overview Table 70. Accelerate Diagnostics, Inc. Single Cell Genomics and Proteomics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 71. Accelerate Diagnostics, Inc. Single Cell Genomics and Proteomics Product Portfolio Table 72. Accelerate Diagnostics, Inc. Recent Development Table 73. Bio-Rad Laboratories, Inc. Company Information Table 74. Bio-Rad Laboratories, Inc. Business Overview Table 75. Bio-Rad Laboratories, Inc. Single Cell Genomics and Proteomics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 76. Bio-Rad Laboratories, Inc. Single Cell Genomics and Proteomics Product Portfolio Table 77. Bio-Rad Laboratories, Inc. Recent Development Table 78. Epic Sciences, Inc. Company Information Table 79. Epic Sciences, Inc. Business Overview Table 80. Epic Sciences, Inc. Single Cell Genomics and Proteomics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 81. Epic Sciences, Inc. Single Cell Genomics and Proteomics Product Portfolio Table 82. Epic Sciences, Inc. Recent Development Table 83. Yikon Genomics Co., Ltd. Company Information Table 84. Yikon Genomics Co., Ltd. Business Overview Table 85. Yikon Genomics Co., Ltd. Single Cell Genomics and Proteomics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 86. Yikon Genomics Co., Ltd. Single Cell Genomics and Proteomics Product Portfolio Table 87. Yikon Genomics Co., Ltd. Recent Development Table 88. Takara Bio Inc. Company Information Table 89. Takara Bio Inc. Business Overview Table 90. Takara Bio Inc. Single Cell Genomics and Proteomics Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 91. Takara Bio Inc. Single Cell Genomics and Proteomics Product Portfolio Table 92. Takara Bio Inc. Recent Development Table 93. 1CellBio, Inc. Company Information Table 94. 1CellBio, Inc. Business Overview Table 95. 1CellBio, Inc. Single Cell Genomics and Proteomics Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 96. 1CellBio, Inc. Single Cell Genomics and Proteomics Product Portfolio Table 97. 1CellBio, Inc. Recent Development Table 98. Bio-Techne Corporation Company Information Table 99. Bio-Techne Corporation Business Overview Table 100. Bio-Techne Corporation Single Cell Genomics and Proteomics Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 101. Bio-Techne Corporation Single Cell Genomics and Proteomics Product Portfolio Table 102. Bio-Techne Corporation Recent Development Table 103. North America Single Cell Genomics and Proteomics Revenue by Type (2021-2026) & (US$ Million) Table 104. North America Single Cell Genomics and Proteomics Revenue by Type (2027-2032) & (US$ Million) Table 105. North America Single Cell Genomics and Proteomics Revenue by Application (2021-2026) & (US$ Million) Table 106. North America Single Cell Genomics and Proteomics Revenue by Application (2027-2032) & (US$ Million) Table 107. North America Single Cell Genomics and Proteomics Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 108. North America Single Cell Genomics and Proteomics Revenue by Country (2021-2026) & (US$ Million) Table 109. North America Single Cell Genomics and Proteomics Revenue by Country (US$ Million) & (2027-2032) Table 110. Europe Single Cell Genomics and Proteomics Revenue by Type (2021-2026) & (US$ Million) Table 111. Europe Single Cell Genomics and Proteomics Revenue by Type (2027-2032) & (US$ Million) Table 112. Europe Single Cell Genomics and Proteomics Revenue by Application (2021-2026) & (US$ Million) Table 113. Europe Single Cell Genomics and Proteomics Revenue by Application (2027-2032) & (US$ Million) Table 114. Europe Single Cell Genomics and Proteomics Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 115. Europe Single Cell Genomics and Proteomics Revenue by Country (2021-2026) & (US$ Million) Table 116. Europe Single Cell Genomics and Proteomics Revenue by Country (US$ Million) & (2027-2032) Table 117. China Single Cell Genomics and Proteomics Revenue by Type (2021-2026) & (US$ Million) Table 118. China Single Cell Genomics and Proteomics Revenue by Type (2027-2032) & (US$ Million) Table 119. China Single Cell Genomics and Proteomics Revenue by Application (2021-2026) & (US$ Million) Table 120. China Single Cell Genomics and Proteomics Revenue by Application (2027-2032) & (US$ Million) Table 121. Asia Single Cell Genomics and Proteomics Revenue by Type (2021-2026) & (US$ Million) Table 122. Asia Single Cell Genomics and Proteomics Revenue by Type (2027-2032) & (US$ Million) Table 123. Asia Single Cell Genomics and Proteomics Revenue by Application (2021-2026) & (US$ Million) Table 124. Asia Single Cell Genomics and Proteomics Revenue by Application (2027-2032) & (US$ Million) Table 125. Asia Single Cell Genomics and Proteomics Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 126. Asia Single Cell Genomics and Proteomics Revenue by Region (US$ Million) & (2021-2026) Table 127. Asia Single Cell Genomics and Proteomics Revenue by Region (US$ Million) & (2027-2032) Table 128. SAMEA Single Cell Genomics and Proteomics Revenue by Type (2021-2026) & (US$ Million) Table 129. SAMEA Single Cell Genomics and Proteomics Revenue by Type (2027-2032) & (US$ Million) Table 130. SAMEA Single Cell Genomics and Proteomics Revenue by Application (2021-2026) & (US$ Million) Table 131. SAMEA Single Cell Genomics and Proteomics Revenue by Application (2027-2032) & (US$ Million) Table 132. SAMEA Single Cell Genomics and Proteomics Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 133. SAMEA Single Cell Genomics and Proteomics Revenue by Country (2021-2026) & (US$ Million) Table 134. SAMEA Single Cell Genomics and Proteomics Revenue by Country (US$ Million) & (2027-2032) Table 135. Research Programs/Design for This Report Table 136. Authors List of This Report Table 137. Secondary Sources Table 138. Primary Sources List of Figures Figure 1. Single Cell Genomics and Proteomics Image Figure 2. Global Single Cell Genomics and Proteomics Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Single Cell Genomics and Proteomics Market Size Share 2021 VS 2025 VS 2032 Figure 4. Cell Isolation Image Figure 5. Sample Preparation Image Figure 6. Genomic Analysis Image Figure 7. Global Single Cell Genomics and Proteomics Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Single Cell Genomics and Proteomics Market Size Share 2021 VS 2025 VS 2032 Figure 9. Genomic Variation Image Figure 10. Subpopulation Characterization Image Figure 11. Circulating Tumor Cells Image Figure 12. Cell Differentiation Image Figure 13. Others Image Figure 14. Global Single Cell Genomics and Proteomics Market Size (US$ Million) & (2021-2032) Figure 15. Global Single Cell Genomics and Proteomics Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 16. Global Single Cell Genomics and Proteomics Market Share by Region: 2021 VS 2025 VS 2032 Figure 17. Global Single Cell Genomics and Proteomics Players Revenue Share Top 10 and Top 5 in 2025 Figure 18. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 19. Global Single Cell Genomics and Proteomics Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Single Cell Genomics and Proteomics Revenue Market Share 2021 VS 2025 VS 2032 Figure 21. Global Single Cell Genomics and Proteomics Revenue Market Share by Type (2021-2032) Figure 22. Global Single Cell Genomics and Proteomics Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Single Cell Genomics and Proteomics Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 24. Global Single Cell Genomics and Proteomics Revenue Market Share by Application (2021-2032) Figure 25. North America Single Cell Genomics and Proteomics Revenue YoY Growth (2021-2032) & (US$ Million) Figure 26. North America Single Cell Genomics and Proteomics Revenue Share by Type (2021-2032) Figure 27. North America Single Cell Genomics and Proteomics Revenue Share by Application (2021-2032) Figure 28. North America Single Cell Genomics and Proteomics Revenue Share by Country (2021-2032) Figure 29. United States Single Cell Genomics and Proteomics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Canada Single Cell Genomics and Proteomics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 31. Mexico Single Cell Genomics and Proteomics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 32. Europe Single Cell Genomics and Proteomics Revenue YoY Growth (2021-2032) & (US$ Million) Figure 33. Europe Single Cell Genomics and Proteomics Revenue Share by Type (2021-2032) Figure 34. Europe Single Cell Genomics and Proteomics Revenue Share by Application (2021-2032) Figure 35. Europe Single Cell Genomics and Proteomics Revenue Share by Country (2021-2032) Figure 36. Germany Single Cell Genomics and Proteomics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. France Single Cell Genomics and Proteomics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. U.K. Single Cell Genomics and Proteomics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Italy Single Cell Genomics and Proteomics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Spain Single Cell Genomics and Proteomics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Russia Single Cell Genomics and Proteomics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Netherlands Single Cell Genomics and Proteomics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. Nordic Countries Single Cell Genomics and Proteomics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 44. China Single Cell Genomics and Proteomics Revenue YoY Growth (2021-2032) & (US$ Million) Figure 45. China Single Cell Genomics and Proteomics Revenue Share by Type (2021-2032) Figure 46. China Single Cell Genomics and Proteomics Revenue Share by Application (2021-2032) Figure 47. Asia Single Cell Genomics and Proteomics Revenue YoY Growth (2021-2032) & (US$ Million) Figure 48. Asia Single Cell Genomics and Proteomics Revenue Share by Type (2021-2032) Figure 49. Asia Single Cell Genomics and Proteomics Revenue Share by Application (2021-2032) Figure 50. Asia Single Cell Genomics and Proteomics Revenue Share by Region (2021-2032) Figure 51. Japan Single Cell Genomics and Proteomics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. South Korea Single Cell Genomics and Proteomics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. India Single Cell Genomics and Proteomics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Australia Single Cell Genomics and Proteomics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. Taiwan Single Cell Genomics and Proteomics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. Southeast Asia Single Cell Genomics and Proteomics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 57. SAMEA Single Cell Genomics and Proteomics Revenue YoY Growth (2021-2032) & (US$ Million) Figure 58. SAMEA Single Cell Genomics and Proteomics Revenue Share by Type (2021-2032) Figure 59. SAMEA Single Cell Genomics and Proteomics Revenue Share by Application (2021-2032) Figure 60. SAMEA Single Cell Genomics and Proteomics Revenue Share by Country (2021-2032) Figure 61. Brazil Single Cell Genomics and Proteomics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Argentina Single Cell Genomics and Proteomics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Chile Single Cell Genomics and Proteomics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Colombia Single Cell Genomics and Proteomics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Peru Single Cell Genomics and Proteomics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Saudi Arabia Single Cell Genomics and Proteomics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Israel Single Cell Genomics and Proteomics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. UAE Single Cell Genomics and Proteomics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Turkey Single Cell Genomics and Proteomics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Iran Single Cell Genomics and Proteomics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Egypt Single Cell Genomics and Proteomics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Cell Isolation
  • Sample Preparation
  • Genomic Analysis
Applications
  • Genomic Variation
  • Subpopulation Characterization
  • Circulating Tumor Cells
  • Cell Differentiation
  • Others
Companies covered
  • 10x Genomics, Inc.
  • Standard BioTools Inc
  • QIAGEN GmbH
  • Thermo Fisher Scientific Inc.
  • Agilent Technologies, Inc.
  • Exact Sciences Corporation
  • Accelerate Diagnostics, Inc.
  • Bio-Rad Laboratories, Inc.
  • Epic Sciences, Inc.
  • Yikon Genomics Co., Ltd.
  • Takara Bio Inc.
  • 1CellBio, Inc.
  • Bio-Techne Corporation

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Single Cell Genomics and Proteomics Market by Type
  3. 1.2.1 Global Single Cell Genomics and Proteomics Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Cell Isolation
  5. 1.2.3 Sample Preparation
  6. 1.2.4 Genomic Analysis
  7. 1.3 Single Cell Genomics and Proteomics Market by Application
  8. 1.3.1 Global Single Cell Genomics and Proteomics Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Genomic Variation
  10. 1.3.3 Subpopulation Characterization
  11. 1.3.4 Circulating Tumor Cells
  12. 1.3.5 Cell Differentiation
  13. 1.3.6 Others
  14. 1.4 Assumptions and Limitations
  15. 1.5 Study Goals and Objectives
2 Single Cell Genomics and Proteomics Market Dynamics
  1. 2.1 Single Cell Genomics and Proteomics Industry Trends
  2. 2.2 Single Cell Genomics and Proteomics Industry Drivers
  3. 2.3 Single Cell Genomics and Proteomics Industry Opportunities and Challenges
  4. 2.4 Single Cell Genomics and Proteomics Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Single Cell Genomics and Proteomics Market Perspective (2021-2032)
  2. 3.2 Global Single Cell Genomics and Proteomics Growth Trends by Region
  3. 3.2.1 Global Single Cell Genomics and Proteomics Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Single Cell Genomics and Proteomics Market Size by Region (2021-2026)
  5. 3.2.3 Global Single Cell Genomics and Proteomics Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Single Cell Genomics and Proteomics Revenue by Players
  2. 4.1.1 Global Single Cell Genomics and Proteomics Revenue by Players (2021-2026)
  3. 4.1.2 Global Single Cell Genomics and Proteomics Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Single Cell Genomics and Proteomics Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Single Cell Genomics and Proteomics Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Single Cell Genomics and Proteomics Key Players Headquarters & Area Served
  7. 4.4 Global Single Cell Genomics and Proteomics Players, Product Type & Application
  8. 4.5 Global Single Cell Genomics and Proteomics Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Single Cell Genomics and Proteomics Market CR5 and HHI
  11. 4.6.3 2025 Single Cell Genomics and Proteomics Tier 1, Tier 2, and Tier 3
5 Single Cell Genomics and Proteomics Market Size by Type
  1. 5.1 Global Single Cell Genomics and Proteomics Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Single Cell Genomics and Proteomics Revenue by Type (2021-2032)
  3. 5.3 Global Single Cell Genomics and Proteomics Revenue Market Share by Type (2021-2032)
6 Single Cell Genomics and Proteomics Market Size by Application
  1. 6.1 Global Single Cell Genomics and Proteomics Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Single Cell Genomics and Proteomics Revenue by Application (2021-2032)
  3. 6.3 Global Single Cell Genomics and Proteomics Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 10x Genomics, Inc.
  2. 7.1.1 10x Genomics, Inc. Company Information
  3. 7.1.2 10x Genomics, Inc. Business Overview
  4. 7.1.3 10x Genomics, Inc. Single Cell Genomics and Proteomics Revenue and Gross Margin (2021-2026)
  5. 7.1.4 10x Genomics, Inc. Single Cell Genomics and Proteomics Product Portfolio
  6. 7.1.5 10x Genomics, Inc. Recent Developments
  7. 7.2 Standard BioTools Inc
  8. 7.2.1 Standard BioTools Inc Company Information
  9. 7.2.2 Standard BioTools Inc Business Overview
  10. 7.2.3 Standard BioTools Inc Single Cell Genomics and Proteomics Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Standard BioTools Inc Single Cell Genomics and Proteomics Product Portfolio
  12. 7.2.5 Standard BioTools Inc Recent Developments
  13. 7.3 QIAGEN GmbH
  14. 7.3.1 QIAGEN GmbH Company Information
  15. 7.3.2 QIAGEN GmbH Business Overview
  16. 7.3.3 QIAGEN GmbH Single Cell Genomics and Proteomics Revenue and Gross Margin (2021-2026)
  17. 7.3.4 QIAGEN GmbH Single Cell Genomics and Proteomics Product Portfolio
  18. 7.3.5 QIAGEN GmbH Recent Developments
  19. 7.4 Thermo Fisher Scientific Inc.
  20. 7.4.1 Thermo Fisher Scientific Inc. Company Information
  21. 7.4.2 Thermo Fisher Scientific Inc. Business Overview
  22. 7.4.3 Thermo Fisher Scientific Inc. Single Cell Genomics and Proteomics Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Thermo Fisher Scientific Inc. Single Cell Genomics and Proteomics Product Portfolio
  24. 7.4.5 Thermo Fisher Scientific Inc. Recent Developments
  25. 7.5 Agilent Technologies, Inc.
  26. 7.5.1 Agilent Technologies, Inc. Company Information
  27. 7.5.2 Agilent Technologies, Inc. Business Overview
  28. 7.5.3 Agilent Technologies, Inc. Single Cell Genomics and Proteomics Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Agilent Technologies, Inc. Single Cell Genomics and Proteomics Product Portfolio
  30. 7.5.5 Agilent Technologies, Inc. Recent Developments
  31. 7.6 Exact Sciences Corporation
  32. 7.6.1 Exact Sciences Corporation Company Information
  33. 7.6.2 Exact Sciences Corporation Business Overview
  34. 7.6.3 Exact Sciences Corporation Single Cell Genomics and Proteomics Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Exact Sciences Corporation Single Cell Genomics and Proteomics Product Portfolio
  36. 7.6.5 Exact Sciences Corporation Recent Developments
  37. 7.7 Accelerate Diagnostics, Inc.
  38. 7.7.1 Accelerate Diagnostics, Inc. Company Information
  39. 7.7.2 Accelerate Diagnostics, Inc. Business Overview
  40. 7.7.3 Accelerate Diagnostics, Inc. Single Cell Genomics and Proteomics Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Accelerate Diagnostics, Inc. Single Cell Genomics and Proteomics Product Portfolio
  42. 7.7.5 Accelerate Diagnostics, Inc. Recent Developments
  43. 7.8 Bio-Rad Laboratories, Inc.
  44. 7.8.1 Bio-Rad Laboratories, Inc. Company Information
  45. 7.8.2 Bio-Rad Laboratories, Inc. Business Overview
  46. 7.8.3 Bio-Rad Laboratories, Inc. Single Cell Genomics and Proteomics Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Bio-Rad Laboratories, Inc. Single Cell Genomics and Proteomics Product Portfolio
  48. 7.8.5 Bio-Rad Laboratories, Inc. Recent Developments
  49. 7.9 Epic Sciences, Inc.
  50. 7.9.1 Epic Sciences, Inc. Company Information
  51. 7.9.2 Epic Sciences, Inc. Business Overview
  52. 7.9.3 Epic Sciences, Inc. Single Cell Genomics and Proteomics Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Epic Sciences, Inc. Single Cell Genomics and Proteomics Product Portfolio
  54. 7.9.5 Epic Sciences, Inc. Recent Developments
  55. 7.10 Yikon Genomics Co., Ltd.
  56. 7.10.1 Yikon Genomics Co., Ltd. Company Information
  57. 7.10.2 Yikon Genomics Co., Ltd. Business Overview
  58. 7.10.3 Yikon Genomics Co., Ltd. Single Cell Genomics and Proteomics Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Yikon Genomics Co., Ltd. Single Cell Genomics and Proteomics Product Portfolio
  60. 7.10.5 Yikon Genomics Co., Ltd. Recent Developments
  61. 7.11 Takara Bio Inc.
  62. 7.11.1 Takara Bio Inc. Company Information
  63. 7.11.2 Takara Bio Inc. Business Overview
  64. 7.11.3 Takara Bio Inc. Single Cell Genomics and Proteomics Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Takara Bio Inc. Single Cell Genomics and Proteomics Product Portfolio
  66. 7.11.5 Takara Bio Inc. Recent Developments
  67. 7.12 1CellBio, Inc.
  68. 7.12.1 1CellBio, Inc. Company Information
  69. 7.12.2 1CellBio, Inc. Business Overview
  70. 7.12.3 1CellBio, Inc. Single Cell Genomics and Proteomics Revenue and Gross Margin (2021-2026)
  71. 7.12.4 1CellBio, Inc. Single Cell Genomics and Proteomics Product Portfolio
  72. 7.12.5 1CellBio, Inc. Recent Developments
  73. 7.13 Bio-Techne Corporation
  74. 7.13.1 Bio-Techne Corporation Company Information
  75. 7.13.2 Bio-Techne Corporation Business Overview
  76. 7.13.3 Bio-Techne Corporation Single Cell Genomics and Proteomics Revenue and Gross Margin (2021-2026)
  77. 7.13.4 Bio-Techne Corporation Single Cell Genomics and Proteomics Product Portfolio
  78. 7.13.5 Bio-Techne Corporation Recent Developments
8 North America
  1. 8.1 North America Single Cell Genomics and Proteomics Revenue (2021-2032)
  2. 8.2 North America Single Cell Genomics and Proteomics Revenue by Type (2021-2032)
  3. 8.2.1 North America Single Cell Genomics and Proteomics Revenue by Type (2021-2026)
  4. 8.2.2 North America Single Cell Genomics and Proteomics Revenue by Type (2027-2032)
  5. 8.3 North America Single Cell Genomics and Proteomics Revenue Share by Type (2021-2032)
  6. 8.4 North America Single Cell Genomics and Proteomics Revenue by Application (2021-2032)
  7. 8.4.1 North America Single Cell Genomics and Proteomics Revenue by Application (2021-2026)
  8. 8.4.2 North America Single Cell Genomics and Proteomics Revenue by Application (2027-2032)
  9. 8.5 North America Single Cell Genomics and Proteomics Revenue Share by Application (2021-2032)
  10. 8.6 North America Single Cell Genomics and Proteomics Revenue by Country
  11. 8.6.1 North America Single Cell Genomics and Proteomics Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Single Cell Genomics and Proteomics Revenue by Country (2021-2026)
  13. 8.6.3 North America Single Cell Genomics and Proteomics Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Single Cell Genomics and Proteomics Revenue (2021-2032)
  2. 9.2 Europe Single Cell Genomics and Proteomics Revenue by Type (2021-2032)
  3. 9.2.1 Europe Single Cell Genomics and Proteomics Revenue by Type (2021-2026)
  4. 9.2.2 Europe Single Cell Genomics and Proteomics Revenue by Type (2027-2032)
  5. 9.3 Europe Single Cell Genomics and Proteomics Revenue Share by Type (2021-2032)
  6. 9.4 Europe Single Cell Genomics and Proteomics Revenue by Application (2021-2032)
  7. 9.4.1 Europe Single Cell Genomics and Proteomics Revenue by Application (2021-2026)
  8. 9.4.2 Europe Single Cell Genomics and Proteomics Revenue by Application (2027-2032)
  9. 9.5 Europe Single Cell Genomics and Proteomics Revenue Share by Application (2021-2032)
  10. 9.6 Europe Single Cell Genomics and Proteomics Revenue by Country
  11. 9.6.1 Europe Single Cell Genomics and Proteomics Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Single Cell Genomics and Proteomics Revenue by Country (2021-2026)
  13. 9.6.3 Europe Single Cell Genomics and Proteomics Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Single Cell Genomics and Proteomics Revenue (2021-2032)
  2. 10.2 China Single Cell Genomics and Proteomics Revenue by Type (2021-2032)
  3. 10.2.1 China Single Cell Genomics and Proteomics Revenue by Type (2021-2026)
  4. 10.2.2 China Single Cell Genomics and Proteomics Revenue by Type (2027-2032)
  5. 10.3 China Single Cell Genomics and Proteomics Revenue Share by Type (2021-2032)
  6. 10.4 China Single Cell Genomics and Proteomics Revenue by Application (2021-2032)
  7. 10.4.1 China Single Cell Genomics and Proteomics Revenue by Application (2021-2026)
  8. 10.4.2 China Single Cell Genomics and Proteomics Revenue by Application (2027-2032)
  9. 10.5 China Single Cell Genomics and Proteomics Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Single Cell Genomics and Proteomics Revenue (2021-2032)
  2. 11.2 Asia Single Cell Genomics and Proteomics Revenue by Type (2021-2032)
  3. 11.2.1 Asia Single Cell Genomics and Proteomics Revenue by Type (2021-2026)
  4. 11.2.2 Asia Single Cell Genomics and Proteomics Revenue by Type (2027-2032)
  5. 11.3 Asia Single Cell Genomics and Proteomics Revenue Share by Type (2021-2032)
  6. 11.4 Asia Single Cell Genomics and Proteomics Revenue by Application (2021-2032)
  7. 11.4.1 Asia Single Cell Genomics and Proteomics Revenue by Application (2021-2026)
  8. 11.4.2 Asia Single Cell Genomics and Proteomics Revenue by Application (2027-2032)
  9. 11.5 Asia Single Cell Genomics and Proteomics Revenue Share by Application (2021-2032)
  10. 11.6 Asia Single Cell Genomics and Proteomics Revenue by Country
  11. 11.6.1 Asia Single Cell Genomics and Proteomics Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Single Cell Genomics and Proteomics Revenue by Country (2021-2026)
  13. 11.6.3 Asia Single Cell Genomics and Proteomics Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Single Cell Genomics and Proteomics Revenue (2021-2032)
  2. 12.2 SAMEA Single Cell Genomics and Proteomics Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Single Cell Genomics and Proteomics Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Single Cell Genomics and Proteomics Revenue by Type (2027-2032)
  5. 12.3 SAMEA Single Cell Genomics and Proteomics Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Single Cell Genomics and Proteomics Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Single Cell Genomics and Proteomics Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Single Cell Genomics and Proteomics Revenue by Application (2027-2032)
  9. 12.5 SAMEA Single Cell Genomics and Proteomics Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Single Cell Genomics and Proteomics Revenue by Country
  11. 12.6.1 SAMEA Single Cell Genomics and Proteomics Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Single Cell Genomics and Proteomics Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Single Cell Genomics and Proteomics Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst